Hyaluronan Receptors
"Hyaluronan Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary THYMOCYTES; GRANULOCYTES; MACROPHAGES; erythrocytes, and fibroblasts. Their interaction with HYALURONIC ACID mediates binding of lymphocytes to high endothelial VENULES.
Descriptor ID |
D018960
|
MeSH Number(s) |
D09.698.735.200.625 D12.776.395.550.200.625.144 D12.776.395.650.750.281 D12.776.543.550.200.625.144 D12.776.543.750.705.877.144 D23.050.301.350.625.144
|
Concept/Terms |
Hyaluronan Receptors- Hyaluronan Receptors
- Hyaluronic Acid Binding Protein
- Hyaluronan-Binding Protein
- Hyaluronan Binding Protein
- CD44 Antigen
- Antigen, CD44
- Receptors, Hyaluronan
- Antigens, CD44
- Hyaluronan Receptor
- Receptor, Hyaluronan
- Chondroitin Sulfate Proteoglycan 8
- CD44 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Hyaluronan Receptors".
Below are MeSH descriptors whose meaning is more specific than "Hyaluronan Receptors".
This graph shows the total number of publications written about "Hyaluronan Receptors" by people in this website by year, and whether "Hyaluronan Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 | 1998 | 1 | 1 | 2 | 1999 | 0 | 1 | 1 | 2000 | 1 | 1 | 2 | 2001 | 1 | 0 | 1 | 2002 | 2 | 2 | 4 | 2003 | 0 | 1 | 1 | 2004 | 0 | 2 | 2 | 2005 | 0 | 1 | 1 | 2006 | 2 | 2 | 4 | 2007 | 2 | 1 | 3 | 2008 | 0 | 2 | 2 | 2009 | 1 | 6 | 7 | 2010 | 0 | 3 | 3 | 2011 | 0 | 2 | 2 | 2012 | 0 | 5 | 5 | 2013 | 0 | 2 | 2 | 2014 | 1 | 1 | 2 | 2016 | 1 | 1 | 2 | 2018 | 0 | 1 | 1 | 2019 | 1 | 1 | 2 | 2020 | 1 | 0 | 1 | 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyaluronan Receptors" by people in Profiles.
-
Xia H, Herrera J, Smith K, Yang L, Gilbertsen A, Benyumov A, Racila E, Bitterman PB, Henke CA. Hyaluronan/CD44 axis regulates S100A4-mediated mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2021 05 01; 320(5):L926-L941.
-
Sottnik JL, Vanderlinden L, Joshi M, Chauca-Diaz A, Owens C, Hansel DE, Sempeck C, Ghosh D, Theodorescu D. Androgen Receptor Regulates CD44 Expression in Bladder Cancer. Cancer Res. 2021 06 01; 81(11):2833-2846.
-
Gomez KE, Wu F, Keysar SB, Morton JJ, Miller B, Chimed TS, Le PN, Nieto C, Chowdhury FN, Tyagi A, Lyons TR, Young CD, Zhou H, Somerset HL, Wang XJ, Jimeno A. Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells. Cancer Res. 2020 10 01; 80(19):4185-4198.
-
Kwon MY, Wang C, Galarraga JH, Pur? E, Han L, Burdick JA. Influence of hyaluronic acid modification on CD44 binding towards the design of hydrogel biomaterials. Biomaterials. 2019 11; 222:119451.
-
Itoh Y, Golden LC, Itoh N, Matsukawa MA, Ren E, Tse V, Arnold AP, Voskuhl RR. The X-linked histone demethylase Kdm6a in CD4+ T lymphocytes modulates autoimmunity. J Clin Invest. 2019 08 12; 129(9):3852-3863.
-
Suda K, Murakami I, Yu H, Kim J, Tan AC, Mizuuchi H, Rozeboom L, Ellison K, Rivard CJ, Mitsudomi T, Hirsch FR. CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer. Mol Cancer Ther. 2018 10; 17(10):2257-2265.
-
Dhar D, Deep G, Kumar S, Wempe MF, Raina K, Agarwal C, Agarwal R. Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. Mol Carcinog. 2018 09; 57(9):1166-1180.
-
Orme IM, Henao-Tamayo MI. Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis. Front Immunol. 2018; 9:461.
-
Keysar SB, Le PN, Miller B, Jackson BC, Eagles JR, Nieto C, Kim J, Tang B, Glogowska MJ, Morton JJ, Padilla-Just N, Gomez K, Warnock E, Reisinger J, Arcaroli JJ, Messersmith WA, Wakefield LM, Gao D, Tan AC, Serracino H, Vasiliou V, Roop DR, Wang XJ, Jimeno A. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. J Natl Cancer Inst. 2017 01; 109(1).
-
Ahmed M, Sottnik JL, Dancik GM, Sahu D, Hansel DE, Theodorescu D, Schwartz MA. An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis Suppression. Cancer Cell. 2016 09 12; 30(3):432-443.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|